Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors

S K Mitra1, D Mikolon, J E Molina

  • 1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Oncogene
|May 10, 2006
PubMed

Insights

Focal adhesion kinase (FAK) promotes tumor growth by enhancing angiogenesis through a MAPK signaling pathway. Inhibiting FAK reduces vascular endothelial growth factor (VEGF) and tumor vascularization, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Focal adhesion kinase (FAK) is upregulated in advanced cancers.
  • The specific signaling role of FAK in tumor progression is not fully understood.

Purpose of the Study:

  • To investigate the signaling role of FAK in tumor progression and angiogenesis.
  • To define the contribution of FAK Y925 phosphorylation to tumor growth.

Main Methods:

  • Suppressed FAK activity in 4T1 breast carcinoma cells.
  • Utilized Src-transformed FAK-null fibroblasts for reconstitution experiments.
  • Analyzed FAK Y925 phosphorylation, Grb2 binding, MAPK signaling, and VEGF expression.
  • Employed constitutively activated MEK1 to rescue VEGF production and tumor growth.

Main Results:

  • FAK inhibition reduced FAK Y925 phosphorylation, Grb2 binding, and MAPK signaling.
  • FAK inhibition decreased vascular endothelial growth factor (VEGF) expression, leading to avascular tumors in mice.
  • Mutations affecting FAK catalytic activity or Y925 phosphorylation impaired tumor growth and angiogenesis.
  • Restoring MAPK signaling or VEGF rescued tumor growth and angiogenesis.

Conclusions:

  • FAK activity, specifically Y925 phosphorylation, is essential for promoting angiogenesis via a MAPK-dependent pathway.
  • FAK plays a novel role in driving the angiogenic switch during tumor progression.
  • Targeting FAK could be a strategy to inhibit tumor angiogenesis and growth.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...